NAD+ Sub-Q vs IV — efficacy gap is real or imagined

N
Joined 2026
35 posts
3/7/2026 · 1574 views

IV NAD+ is the gold standard for serious protocols. Sub-Q is cheaper and easier. For longevity-adjacent goals (not clinical conditions), does Sub-Q cover the use case?

6 Replies

T
Joined 2026
30 posts
3/8/2026

Sub-Q at 100mg 2x/week covers general longevity use. IV is overkill unless you're running clinical-dose protocols for addiction or neurodegenerative stuff.

M
Joined 2026
41 posts
motsc_opsMember
3/9/2026

Sub-Q is slower release and you avoid the acute IV flush. For chronic support it's arguably better. For acute high-dose loading, IV wins.

C
Joined 2026
71 posts
3/10/2026

PK data for Sub-Q NAD+ is limited but extrapolating from pyridine nucleotide class, Sub-Q gives a broader AUC with lower peak vs IV. For longevity use case, probably equivalent or better.

N
Joined 2026
35 posts
3/11/2026

Thanks all. Going to stay Sub-Q. The IV clinics charge 3-5x for a marginal acute difference that isn't the use case I need.

T
Joined 2026
21 posts
4/22/2026

yeah sub-q is fine for what most people actually need. the iv clinic marketing is real strong but unless you're doing like 500mg+ protocols or trying to reverse actual damage, you're just paying for the experience of feeling like you're doing something more serious. i did both for a year and honestly couldn't tell the difference on any markers that mattered to me.

S
Joined 2026
29 posts
18d ago

honestly the whole sub-q vs iv thing feels overblown when most people aren't even consistent with basic stuff like sleep and training. i ran sub-q for like 6 months and switched back to nothing just to see if i could tell and literally couldn't on any metric that mattered. which is wild bc i was spending money on it lol. at that point you're just paying for the ritual of it, the feeling that you're Doing Science™ at home with a needle. not saying don't do it but yeah the marketing around IV clinics is nuts when the actual data gap is pretty small for the use case most people have.

Sign in to reply.